Correlation Between Aerovate Therapeutics and BROADCOM

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and BROADCOM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and BROADCOM into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and BROADCOM INC 144A, you can compare the effects of market volatilities on Aerovate Therapeutics and BROADCOM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of BROADCOM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and BROADCOM.

Diversification Opportunities for Aerovate Therapeutics and BROADCOM

-0.69

Correlation Coefficient

Aerovate Therapeutics  BROADCOM

Excellent diversification

The 3 months correlation between Aerovate and BROADCOM is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and BROADCOM INC 144A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BROADCOM INC 144A and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with BROADCOM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BROADCOM INC 144A has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and BROADCOM go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and BROADCOM

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the BROADCOM. In addition to that, Aerovate Therapeutics is 2.14 times more volatile than BROADCOM INC 144A. It trades about -0.07 of its total potential returns per unit of risk. BROADCOM INC 144A is currently generating about -0.09 per unit of volatility. If you would invest  7,476  in BROADCOM INC 144A on September 14, 2024 and sell it today you would lose (145.00) from holding BROADCOM INC 144A or give up 1.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  BROADCOM INC 144A

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

BROADCOM INC 144A

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BROADCOM INC 144A has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for BROADCOM INC 144A investors.

Pair Trading with Aerovate Therapeutics and BROADCOM

The main advantage of trading using opposite Aerovate Therapeutics and BROADCOM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, BROADCOM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BROADCOM will offset losses from the drop in BROADCOM's long position.

The idea behind Aerovate Therapeutics and BROADCOM INC 144A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.